Frédéric Lévy

3.8k citations

61 papers · 3.1k indexed · h-index 30

Impact in

Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 5%
- CAR-T cell therapy research

Papers in ⓘ

Immunology 37
- Immunotherapy and Immune Responses 33
- T-cell and B-cell Immunology 18
- Immune Cell Function and Interaction 16
Molecular Biology 35
- vaccines and immunoinformatics approaches 17
- Ubiquitin and proteasome pathways 12
- RNA Interference and Gene Delivery 5

Co-authors: Jean‐Charles Cerottini (10 shared papers)Alexander Varshavsky (3 shared papers)Pedro Romero (14 shared papers)Philippe Guillaume (7 shared papers)R. Jürgen Dohmen (2 shared papers)Laurence Chapatte (7 shared papers)Michel Ghislain (1 shared paper)Danila Valmori (9 shared papers)
Journals: The Journal of Immunology (7 papers)Journal of Biological Chemistry (4 papers)European Journal of Immunology (4 papers)International Journal of Cancer (3 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: Switzerland United States Belgium

In The Last Decade

Frédéric Lévy

61 papers receiving 3.1k citations

Peers

Countries citing papers authored by Frédéric Lévy

Since Specialization

Citations

This map shows the geographic impact of Frédéric Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Lévy more than expected).

Fields of papers citing papers by Frédéric Lévy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Lévy. The network helps show where Frédéric Lévy may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Lévy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Lévy Line = papers co-authored together Frédéric Lévy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Processing of Some Antigens by the Standard Proteasome but Not by the Immunoproteasome Results in Poor Presentation by Dendritic Cells Immunity ·Sandra Morel, Frédéric Lévy, Odile Burlet‐Schiltz, Francis Brasseur, Michael Probst‐Kepper, Anne-Lise Peitrequin, Bernard Monsarrat, Robert Van Velthoven, Jean‐Charles Cerottini, Thierry Boon, Jean Edouard Gairin, Benoı̂t J. Van den Eynde	2000	349
2	Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces cerevisiae. The EMBO Journal ·Michel Ghislain, R. Jürgen Dohmen, Frédéric Lévy, Alexander Varshavsky	1996	231
3	Cross-presenting human γδ T cells induce robust CD8 ⁺ αβ T cell responses Proceedings of the National Academy of Sciences ·Marlène Brandes, Katharina Willimann, Gilles Bioley, Nicole Lévy, Matthias Eberl, Ming Luo, Robert Tampé, Frédéric Lévy, Pedro Romero, Bernhard Moser	2009	211
4	Antigenicity and immunogenicity of Melan‐A/MART‐1 derived peptides as targets for tumor reactive CTL in human melanoma Immunological Reviews ·Pedro Romero, Danila Valmori, Mikäel J. Pittet, Alfred Zippelius, Donata Rimoldi, Frédéric Lévy, Valérie Dutoit, Maha Ayyoub, Verena Rubio‐Godoy, Olivier Michielin, Philippe Guillaume, Pascal Batard, Immanuel F. Luescher, Ferdy J. Lejeune, Danielle Líénard, Nathalie Rufer, Pierre‐Yves Dietrich, Daniel E. Speiser, Jean‐Charles Cerottini	2002	128
5	In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8+ T cell responses Journal of Clinical Investigation ·Christoph Esslinger, Laurence Chapatte, Daniela Finke, Isabelle Miconnet, Philippe Guillaume, Frédéric Lévy, H. Robson MacDonald	2003	120
6	In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8+ T cell responses Journal of Clinical Investigation ·Christoph Esslinger, Laurence Chapatte, Daniela Finke, Isabelle Miconnet, Philippe Guillaume, Frédéric Lévy, H. Robson MacDonald	2003	114
7	Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity Nature Medicine ·Lukas Flatz, Ahmed N. Hegazy, Andreas Bergthaler, Admar Verschoor, Christina Claus, Marylise Fernandez, Luca Gattinoni, Susan Johnson, Florian Kreppel, Stefan Kochanek, Maries van den Broek, Andreas Radbruch, Frédéric Lévy, Paul‐Henri Lambert, Claire-Anne Siegrist, Nicholas P. Restifo, Max Löhning, Adrian F. Ochsenbein, Gary J. Nabel, Daniel D. Pinschewer	2010	106
8	Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3 The Journal of Experimental Medicine ·Danila Valmori, Uzi Gileadi, Catherine Servis, P. Rod Dunbar, Jean‐Charles Cerottini, Pedro Romero, Vincenzo Cerundolo, Frédéric Lévy	1999	105
9	Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma The Journal of Immunology ·Maha Ayyoub, Stefan Stevanović, Uğur Şahin, Philippe Guillaume, Catherine Servis, Donata Rimoldi, Danila Valmori, Pedro Romero, Jean‐Charles Cerottini, Hans‐Georg Rammensee, Michael Pfreundschuh, Daniel E. Speiser, Frédéric Lévy	2002	100
10	A Role for cis Interaction between the Inhibitory Ly49A Receptor and MHC Class I for Natural Killer Cell Education Immunity ·Anick Chalifour, Léonardo Scarpellino, Jonathan Back, Petter Brodin, Estelle Devêvre, Frédéric Gros, Frédéric Lévy, Georges Leclercq, Petter Höglund, Friedrich Beermann, Werner Held	2009	99
11	The Production of a New MAGE-3 Peptide Presented to Cytolytic T Lymphocytes by HLA-B40 Requires the Immunoproteasome The Journal of Experimental Medicine ·Erwin Schultz, Jacques Chapiro, Christophe Lurquin, Stéphane Claverol, Odile Burlet‐Schiltz, Guy Warnier, Vincenzo Russo, Sandra Morel, Frédéric Lévy, Thierry Boon, Benoı̂t J. Van den Eynde, Pierre van der Bruggen	2002	99
12	Using ubiquitin to follow the metabolic fate of a protein. Proceedings of the National Academy of Sciences ·Frédéric Lévy, Nils Johnsson, Till Rümenapf, Alexander Varshavsky	1996	88
13	The retinal pigment epithelial membrane receptor for plasma retinol-binding protein. Isolation and cDNA cloning of the 63-kDa protein. Journal of Biological Chemistry ·Claes Båvik, Frédéric Lévy, Ulf Hellman, Christer Wernstedt, Ulf Eriksson	1993	84
14	ATP is required for in vitro assembly of MHC class I antigens but not to transfer of peptides acrosss the ER membrane Cell ·Frédéric Lévy, Reinhard Gabathuler, Roger Larsson, Sune Kvist	1991	79
15	Identification and characterization of a mammalian protein interacting with 20S proteasome precursors Proceedings of the National Academy of Sciences ·Lena Burri, Jörg Höckendorff, Ulrich Boehm, Thorsten Klamp, R. Jürgen Dohmen, Frédéric Lévy	2000	73
16	Lack of tumor recognition by hTERT peptide 540-548-specific CD8+ T cells from melanoma patients reveals inefficient antigen processing European Journal of Immunology ·Maha Ayyoub, Marco Migliaccio, Philippe Guillaume, Danielle Líénard, Jean‐Charles Cerottini, Pedro Romero, Frédéric Lévy, Daniel E. Speiser, Danila Valmori	2001	71
17	Interactions of Ly49 Family Receptors with MHC Class I Ligands in trans and cis The Journal of Immunology ·Léonardo Scarpellino, Franziska M. Oeschger, Philippe Guillaume, Jérôme D. Coudert, Frédéric Lévy, Georges Leclercq, Werner Held	2007	70
18	The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases The Journal of Immunology ·Frédéric Lévy, Lena Burri, Sandra Morel, Anne-Lise Peitrequin, Nicole Lévy, Angela Bachi, Ulf Hellman, Benoı̂t J. Van den Eynde, Catherine Servis	2002	67
19	Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue The Journal of Immunology ·Danila Valmori, Frédéric Lévy, Isabelle Miconnet, Paul Zajac, Giulio C. Spagnoli, Donata Rimoldi, Danielle Líénard, Vincenzo Cerundolo, Jean‐Charles Cerottini, Pedro Romero	2000	64
20	The Melanocytic Protein Melan‐A/MART‐1 Has a Subcellular Localization Distinct from Typical Melanosomal Proteins Traffic ·Ann M. De Mazière, Katja Muehlethaler, Elly van Donselaar, Suzanne Salvi, Jean Davoust, Jean‐Charles Cerottini, Frédéric Lévy, Jan W. Slot, Donata Rimoldi	2002	64

About Frédéric Lévy

Frédéric Lévy is a scholar working on Immunology, Molecular Biology, Oncology, Cell Biology and Epidemiology, having authored 61 papers that have together received 3.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (33 papers), T-cell and B-cell Immunology (18 papers), vaccines and immunoinformatics approaches (17 papers), Immune Cell Function and Interaction (16 papers), Ubiquitin and proteasome pathways (12 papers), Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Immunology (1.9k citations), Oncology (957 citations), Molecular Biology (1.6k citations), Cell Biology (347 citations) and Genetics (380 citations). Frédéric Lévy has collaborated with scholars based in Switzerland, United States and Belgium. Frequent co-authors include Jean‐Charles Cerottini, Alexander Varshavsky, Pedro Romero, Philippe Guillaume, R. Jürgen Dohmen, Laurence Chapatte, Michel Ghislain, Danila Valmori, Benoı̂t J. Van den Eynde and Sandra Morel. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, European Journal of Immunology, International Journal of Cancer and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact